Rapid Vaccination of Hard-To-Reach Populations
|ClinicalTrials.gov Identifier: NCT00155974|
Recruitment Status : Unknown
Verified September 2005 by The New York Academy of Medicine.
Recruitment status was: Recruiting
First Posted : September 12, 2005
Last Update Posted : September 22, 2006
The purpose of this study is to develop and determine the effectiveness of a multi-level community participatory intervention designed to rapidly immunize hard-to-reach populations, including substance users, within disadvantaged minority communities.
Specific Aims of the project are as follows:
- To identify the relative contributions of personal factors and structural barriers to immunization status in hard-to-reach populations.
- To estimate the size of the hard-to-reach population in specified disadvantaged urban communities using venue-based sampling, probability-based sampling, capture-recapture methods and modified Delphi techniques.
- To compare vaccination rates in hard-to-reach populations between neighborhoods that receive a community-based vaccine outreach intervention versus neighborhoods where vaccines are offered through standard public health programs, using an incremental crossover multilevel community intervention design.
|Condition or disease||Intervention/treatment||Phase|
|Influenza||Biological: Community-based vaccine outreach intervention||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||4000 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||None (Open Label)|
|Official Title:||Rapid Vaccination of Hard-to-Reach Populations|
|Study Start Date :||February 2004|
|Study Completion Date :||October 2005|
- Compare vaccination rates in selected neighborhoods before and after a multilevel community-based participatory intervention trial.
- Determine and identify the relative contributions of personal factors and structural barriers to immunization status in hard-to-reach populations.
- Estimate the size of the hard-to-reach populations.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00155974
|Contact: Sandro Galea, MD, DrPHemail@example.com|
|Contact: Micaela H Coady, MSfirstname.lastname@example.org|
|United States, New York|
|Center for Urban Epidemiologic Studies, The New York Academy of Medicine||Recruiting|
|New York, New York, United States, 10029|
|Contact: Micaela H Coady, MS 212-822-7277 email@example.com|
|Contact: Danielle Ompad, PhD 212-419-3589 firstname.lastname@example.org|
|Principal Investigator: David Vlahov, PhD|
|Principal Investigator: Sandro Galea, MD, DrPH|
|Principal Investigator:||David Vlahov, PhD||Center for Urban Epidemiologic Studies, The New York Academy of Medicine|
|Principal Investigator:||Sandro Galea, MD, DrPH||Center for Urban Epidemiologic Studies, The New York Academy of Medicine|